Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RIPTACs: A groundbreaking approach to drug discovery

Drug Discovery Today(2023)10.1016/j.drudis.2023.103774Source: DataRank Database

RIPTACs: A groundbreaking approach to drug discovery is a research paper published in Drug Discovery Today (2023). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

gen nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Topics (9)IDs (PubMed, PMC)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Andrew A. Bolinger,Jia Zhou ORCID,Zonghui Ma ORCID

Live enrichment

PubMed:37734702 PMC:PMC11144445

Foundation for the National Institutes of Health

Grant: T32 DA007287

Cancer Prevention and Research Institute of Texas

Grant: RP210062

National Institutes of Health

MeSH Terms

ProteinsDrug Discovery

Keywords

Cancer therapyTernary complexProtein–protein Interactions (Ppis)Bifunctional MoleculesRiptacsEffector Protein (Ep)Target Protein (Tp)

RIPTACs: A groundbreaking approach to drug discovery

FAIR Checklist

Authors (3)

Funding (3 grants)

Topics

Annotations (Europe PMC)